The long-term symptoms of COVID-19 are the subject of public and scientific discussions. Understanding how those long COVID symptoms co-occur in clusters of syndromes may indicate the pathogenic mechanisms of long COVID. Our study objective was to …

Multisystem inflammatory syndrome in children (MIS-C), is a rare but severe, hyperinflammatory complication of COVID-19, in which cardiovascular abnormalities are frequently detected. In this prospective study, we describe the echocardiographic …

A considerable proportion of patients infected with the coronavirus SARS-CoV-2 reports persisting symptoms such as fatigue, dyspnea, and cognitive problems, for weeks or months after the acute coronavirus disease 2019 (COVID-19) [ 1 – 4 ]. This …

The ongoing COVID-19 pandemic has precipitated a worldwide health catastrophe, impacting not only the physical health of those infected but also their emotional stability [ 1 ]. Post-COVID-19 syndrome, which pertains to the persistence of symptoms …

Long Covid-19 syndrome (LCS) manifests with a wide range of clinical symptoms, yet the factors associated with LCS remain poorly understood. The current study aimed to investigate the relationships that demographic characteristics, clinical …

Following COVID-19 infection, as many as a third to a half of patients are left with long-term symptoms, known as post-acute sequelae of SARS-CoV-2 infection (PASC). 1 – 4 PASC has been defined as a condition where symptoms continue for more than …

Post-acute sequelae of COVID-19 can present as multi-organ pathology, with neuropsychiatric symptoms being the most common symptom complex, characterizing long COVID as a syndrome with a significant disease burden for affected individuals. Several …

After initial SARS-CoV-2 infection, an estimated 5–10% of individuals develop persistent symptoms [ 1 ]. The World Health Organization defines “long COVID” as symptoms lasting for at least 2 months, at least 3 months after the onset of COVID-19 …

It is well known that SARS-CoV-2 leads to several neurological manifestations, including large-vessel strokes, seizures at onset, muscle pain, and para-infectious neuropathies. The neurological involvement is due to different mechanisms of action …

The COVID-19 pandemic caused by the coronavirus 2 of the severe acute respiratory syndrome (SARS-CoV-2) has significantly affected people around the world, leading to substantial morbidity and mortality. Although the pandemic has affected people …

Coronavirus disease-2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) infection, which emerged as a global pandemic towards the end of 2019 [ 1 , 2 ]. SARS-CoV2 had a pandemic potential, unlike the …

The coronavirus disease 2019 (COVID-19) pandemic has incepted a surge of mechanically ventilated patients suffering from acute respiratory distress syndrome (ARDS), who have demonstrated to be characteristically complex to sedate and require high …

The new coronavirus SARS-CoV-2 rapidly spread around the world, turning into a pandemic [ 1 , 2 ]. SARS-CoV-2 enters cells through interaction with angiotensin converting enzyme-2 (ACE2) receptors present in many cell types, including nasal mucosa …

Myofascial pain (MP) is a complex health condition that affects many patients, and is thought to occur from muscle overuse, trauma, and psychological stress [ 1 ]. The loci of the pain are termed “trigger points,” which are tender spots in a taut …

Being initially reported as a pure respiratory infection, it became quickly apparent that Coronavirus disease 2019 (COVID-19) is a multi-organ disease, giving rise to cardiovascular, renal, gastrointestinal, hepatic, hematological, metabolic, and …

It is known that during the active course of Coronavirus disease 2019 (COVID-19), myocardial injury has an established pathological base, while its myocardial injury post-recovery is still obscured.The aim of this study was to evaluate the …